BioSerenity

BioSerenity is a major player in medical technologies and connected health. The company develops medical devices (ECG, EMG, EEG, temperature, etc.) as well as services for various medical specialties such as neurology, cardiology or sleep disorders, through its subsidiaries in France and in the United States.

BioSerenity is one of the few companies offering managed-care services to its customers, by developing front end to back end computer systems for monitoring solutions that are used as a companion diagnostic tool in combination with treatment. This also includes hardware medical devices, mobile apps, a secure online Cloud plateforme, Artificial Intelligence, and remote specialist services for data analysis on a 24/7 basis.

BioSerenity was originally founded within the ICM (icm-institute.org), part of the biggest European hospital, a unique environment for scientific and medical innovations, data science and IT development. In 2019, BioSerenity acquired US-based SleepMed Inc., Digitrace Inc. and Novasom Inc., and now designs its devices and provides its services worldwide, and already works with more than 350 hospitals around the world.

With more than 500 employees and nearly €85M raised since its launch in 2014, BioSerenity benefited from rapid growth, a booming market and above all from an ambitious multidisciplinary team capable to meet the health challenges of tomorrow.